These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6461913)

  • 1. [Selection of donors for allogeneic bone marrow grafts].
    Muller JY
    Rev Fr Transfus Immunohematol; 1982 Feb; 25(1):57-74. PubMed ID: 6461913
    [No Abstract]   [Full Text] [Related]  

  • 2. Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.
    Ildstad ST; Wren SM; Oh E; Hronakes ML
    Transplantation; 1991 Jun; 51(6):1262-7. PubMed ID: 1828637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of non-HLA systems and the feasibility of the use of unrelated donors in bone marrow transplantation.
    van Rood JJ; van Leeuwen A; Goulmy E; Termijtelen A; Bradley BA; Brand A; Eernisse JG
    Transplant Proc; 1978 Mar; 10(1):47-51. PubMed ID: 24909
    [No Abstract]   [Full Text] [Related]  

  • 4. RISH III. Haplotype-sharing in immune responses.
    Daunter B
    Med Hypotheses; 1985 May; 17(1):79-93. PubMed ID: 3892253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histocompatibility and marrow transplantation.
    Hansen JA; Clift RA; Thomas ED; Buckner CD; Mickelson EM; Storb R
    Transplant Proc; 1979 Dec; 11(4):1924-9. PubMed ID: 43613
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone marrow transplantation: cellular engineering to correct primary immunodeficiency, aregenerative anemia and pancytopenia.
    Good RA
    Birth Defects Orig Artic Ser; 1975; 11(1):377-9. PubMed ID: 238679
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of H-2 mutants as models for the study of T cell activation.
    McKenzie IF; Pang T; Blanden RV
    Immunol Rev; 1977; 35():179-230. PubMed ID: 70397
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matching for donor--host compatibility for bone marrow transplantation.
    Amos DB
    Transplant Proc; 1976 Dec; 8(4):687-92. PubMed ID: 11597
    [No Abstract]   [Full Text] [Related]  

  • 10. Graft-vs-host tolerance in mixed allogeneic chimerism.
    Kawai T; Sachs DH; Hoshino T; Koga S; Tanabe K; Toma H; Ota K; Colvin RB; Cosimi AB
    Transplant Proc; 1997; 29(1-2):1222-3. PubMed ID: 9123283
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone marrow transplantation across the major histocompatibility barrier in specific-pathogen-free mice: effects of intact versus T cell-depleted bone marrow on the expression of anti-host reaction in the recipient spleens.
    Muto M; Sado T; Aizawa S; Kamisaku H; Kubo E
    J Immunol; 1981 Dec; 127(6):2421-5. PubMed ID: 6457876
    [No Abstract]   [Full Text] [Related]  

  • 12. Bone marrow transplanation for severe combined immunodeficiency with the HL-A-incompatible but MLC-identical mother as a donor.
    Neithammer D; Goldmann SF; Haas RJ; Dietrich M; Flad HD; Fliedner TM; Kleihauer E
    Transplant Proc; 1976 Dec; 8(4):623-8. PubMed ID: 11594
    [No Abstract]   [Full Text] [Related]  

  • 13. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
    Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
    J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific tolerance and immunocompetence in haploidentical, but not in completely allogeneic, canine chimeras treated with methotrexate and cyclosporine.
    Deeg HJ; Severns E; Raff RF; Sale GE; Storb R
    Transplantation; 1987 Nov; 44(5):621-32. PubMed ID: 2961110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular immunogenetics of HLA: quantitative crossmatches for LD and CD determinants.
    Bach FH
    Transplant Proc; 1978 Mar; 10(1):63-6. PubMed ID: 76353
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies of immunologic tolerance to host minor histocompatibility antigens following allogeneic bone marrow transplantation in mice.
    Perreault C; Allard A; Brochu S; Poupart C; Fontaine P; Bélanger R; Gyger M
    Bone Marrow Transplant; 1990 Aug; 6(2):127-35. PubMed ID: 2145050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of related and unrelated bone marrow donors.
    Goldmann SF
    Transplant Proc; 1977 Mar; 9(1):507-11. PubMed ID: 17197
    [No Abstract]   [Full Text] [Related]  

  • 18. The MHC in human bone marrow allotransplantation.
    Yunis EJ; Awdeh Z; Raum D; Alper CA
    Clin Haematol; 1983 Oct; 12(3):641-80. PubMed ID: 6227438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antigenic characteristics of hematopoietic stem cells.
    Fitchen JH; Foon KA; Cline MJ
    N Engl J Med; 1981 Jul; 305(1):17-25. PubMed ID: 6785649
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural killer cells and their possible relevance to transplantation biology.
    Herberman RB
    Transplantation; 1982 Jul; 34(1):1-7. PubMed ID: 6214877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.